Trials / Sponsors / Shenzhen BinDeBio Ltd.
Shenzhen BinDeBio Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood, Relapsed/Refractory B-cell Lymphoma, Childhood | Phase 1 | 2019-10-08 |
| Unknown | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies Esophagus Cancer, Hepatoma, Glioma | Phase 1 / Phase 2 | 2019-09-01 |
| Unknown | Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer Pancreatic Cancer | N/A | 2018-07-11 |
| Unknown | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies B-cell Acute Lymphoblastic Leukemia, Lymphoma, Myeloid Leukemia | Phase 1 / Phase 2 | 2018-03-01 |
| Unknown | A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects Relapsed B-cell Acute Lymphoblastic Leukemia, Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed／Refractory B-cell Lymphoma | Phase 1 / Phase 2 | 2017-03-02 |
| Unknown | A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subj Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood, Relapsed/Refractory B-cell Lymphoma, Childhood | Phase 1 / Phase 2 | 2016-11-01 |